Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
4.250
-0.020 (-0.47%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Intensity Therapeutics Employees
As of December 31, 2025, Intensity Therapeutics had 7 total employees, including 5 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,594,714
Market Cap
13.88M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | 0 | - | 5 | 2 |
| Dec 31, 2024 | 7 | 0 | - | 5 | 2 |
| Dec 31, 2023 | 7 | 3 | 75.00% | 5 | 2 |
| Mar 31, 2023 | 4 | -2 | -33.33% | 3 | 1 |
| Jun 30, 2022 | 4 | - | - | 4 | 0 |
| Mar 31, 2022 | 6 | - | - | 5 | 1 |
| Dec 31, 2021 | 6 | - | - | 5 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Passage Bio | 24 |
| BioLineRx | 24 |
| SeaStar Medical Holding | 18 |
| Moleculin Biotech | 17 |
| AEON Biopharma | 8 |
| Phio Pharmaceuticals | 6 |
| KALA BIO | 6 |
| Adial Pharmaceuticals | 5 |
INTS News
- 12 days ago - Intensity Therapeutics price target raised to $7 from $5 at H.C. Wainwright - TheFly
- 19 days ago - Intensity Therapeutics price target lowered to $15 from $30 at Alliance Global - TheFly
- 19 days ago - Intensity Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 19 days ago - Intensity Therapeutics Quarterly report: Q2 2026 - Filings
- 19 days ago - Intensity Therapeutics Earnings release: Q2 2026 - Filings
- 19 days ago - Intensity Therapeutics reports Q2 EPS ($1.11), consensus (77c) - TheFly
- 19 days ago - Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - PRNewsWire
- 26 days ago - Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026 - PRNewsWire